Knowledge Center
Patent / Jan 01, 1971
Mineral hydroxy acid esters of 9.alpha.-fluoro-16-methylprednisolone
Source:
US 3564028
Prepn. of the title compds., useful for the remission of pain, bleeding tendency, and fever, is described. Orthophosphoric acid (85%) is dehydrated; MeCN and Et3N added and the mixt. cooled to -20.degree. and ClCO2Et in MeCN added. The mixt. is stirred 0.5 hr followed by the addn. of prednisolone in MeCN and Et3N. The mixt. is refluxed 1 hr, and 2N NaOMe in MeOH added to yield Na salt of prednisolone 21-phosphate, m. 200.degree.. Similarly are prepd. 6 addnl. analogs.
Also in the Knowledge Center
/ Dec 28, 2023
Pharmaceutical composition containing sugar and lipid composite particles for inhalation and method for manufacturing same
Read more
Scientific Article
/ Jan 11, 2024
Dry powder inhaler pharmaceutical composition of coated crystalline dry powder for inhalation
Read more
Scientific Article
/ Nov 12, 2024
Webinar - Solving the Insoluble: Webinar on the Science and Application of the Dispersome® Technology
Read more
Scientific Article